Όλο το DSpace

Πλοήγηση ανά Θέμα "brentuximab vedotin"

Αποτελέσματα 1-2 από 2

    • Acinetobacter baumannii antibiotic resistance mechanisms 

      Kyriakidis I., Vasileiou E., Pana Z.D., Tragiannidis A. (2021)
      Acinetobacter baumannii is a Gram-negative ESKAPE microorganism that poses a threat to public health by causing severe and invasive (mostly nosocomial) infections linked with high mortality rates. During the last years, ...

    • Brentuximab vedotin in relapsed/refractory Hodgkin lymphoma. The Hellenic experience 

      Angelopoulou M.K., Vassilakopoulos T.P., Batsis I., Sakellari I., Gkirkas K., Pappa V., Giannoulia P., Apostolidis I., Apostolopoulos C., Roussou P., Panayiotidis P., Dimou M., Kyrtsonis M.-C., Palassopoulou M., Vassilopoulos G., Moschogiannis M., Kalpadakis C., Margaritis D., Spyridonidis A., Michalis E., Anargyrou K., Repousis P., Hatzimichael E., Bousiou Z., Poulakidas E., Grentzelias D., Harhalakis N., Pangalis G.A., Anagnostopoulos A., Tsirigotis P. (2018)
      This retrospective study aimed to describe the Hellenic experience on the use of brentuximab vedotin (BV) in relapsed/refractory (R/R) Hodgkin lymphoma (HL) given within its indication. From June 2011 to April 2015, ...